TNXP News 10.03 Tonix Pharm Hldg Cor (TNXP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tonix Pharm Hldg Cor (TNXP) 10.03 $TNXP

Tonix Pharmaceuticals Spotlighted in April 7 Issue of BioCentury
GlobeNewswire - Wed Apr 09, 8:22AM CDT
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage pharmaceutical company, was spotlighted in the April 7, 2014 issue of BioCentury: The Bernstein Report on BioBusiness.

Nasdaq stocks posting largest percentage increases
AP - Tue Apr 01, 12:45PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Tonix Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Regulatory Affairs
GlobeNewswire - Tue Apr 01, 8:25AM CDT
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice President, Clinical Development and Regulatory Affairs. Dr. Kellerman will be responsible for overseeing strategy and execution of Tonix's clinical programs.

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 31, 9:27AM CDT
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced financial results for the fourth quarter and full year ended December 31, 2013.

Tonix Pharmaceuticals to Present at the ROTH Conference
GlobeNewswire - Wed Mar 05, 7:20AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 26 Annual ROTH Conference in Laguna Niguel, California. Seth Lederman, M.D., president and CEO of Tonix, will deliver a corporate overview on Tuesday, March 11, 2014 at 12:30 PM PT.

Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA on TNX-201 for Episodic Tension-Type Headache: Clinical Development to Begin in 4Q 2014
GlobeNewswire - Mon Mar 03, 8:35AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulatory pathway for the development of TNX-201 (single isomer isometheptene, or IMH) for the relief of episodic tension-type headache (ETTH). ETTH is the medically-recognized term for tension headache, a common problem affecting approximately 20% of the global adult population.

Tonix Pharmaceuticals Spotlighted in Three Media Outlets in February
GlobeNewswire - Fri Feb 21, 7:20AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, has been featured in TheStreet.com, Genetic Engineering & Biotechnology News and Drug Discovery News during the month of February.

Tonix Pharmaceuticals to Present at the BIO CEO Conference
GlobeNewswire - Tue Feb 04, 9:48PM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 16 Annual BIO CEO & Investor Conference in New York City. Seth Lederman, M.D., president and CEO of Tonix, will deliver a corporate overview on Monday, February 10, 2014 at 4:00 PM ET.

Tonix Pharmaceuticals Announces Closing of $43.5 Million Public Offering of Common Stock
GlobeNewswire - Wed Jan 29, 10:15AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 2,898,550 shares of its common stock. The shares were sold at the public offering price of $15.00 per share, bringing the aggregate gross proceeds from the offering to approximately $43.5 million, before deducting underwriting discounts and commissions and other offering expenses.

Tonix Pharmaceuticals Holding Corp expects USD43.5m in public offering
M2 - Mon Jan 27, 6:44AM CST
Prescription medication company Tonix Pharmaceuticals Holding Corp (NasdaqCM:TNXP) stated on Friday that it has priced its public offering of 2,898,550 shares of its common stock.

Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
GlobeNewswire - Fri Jan 24, 7:20AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the pricing of an underwritten public offering of 2,898,550 shares of its common stock at a price of $15.00 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 434,782 shares to cover overallotments in connection with the offering. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $40.7 million, assuming no exercise of the overallotment option. The offering is expected to close on January 29, 2014, subject to customary closing conditions.

Tonix Pharmaceuticals Holding Corp to launch public offering of common shares
M2 - Fri Jan 24, 5:12AM CST
Pharmaceutical company Tonix Pharmaceuticals Holding Corp (NasdaqCM:TNXP) said on Thursday that it plans to offer shares of its common stock in an underwritten public offering.

Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire - Thu Jan 23, 3:02PM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Can the Rally in Tonix Pharmaceuticals Holding Corp. (TNXP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 8:25AM CST
Can the Rally in Tonix Pharmaceuticals Holding Corp. (TNXP) Shares Continue?

5 Stocks Rising on Unusual Volume
at The Street - Fri Dec 27, 9:13AM CST
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Nansha's Trade Pitch Has Numbers, but Questions Remain

Updated Category News Views 61

A Chilean cherry spending 22 days at sea can tell an investor plenty about where Guangzhou's Nansha District wants to sit in Asia-Pacific commerce. Not glamorous, no. But trade infrastructure rarely is until volumes pile up, routes deepen, and somebody else finds they cannot easily replicate the network. Nansha is using the expected 33rd APEC Economic Leaders' Meeting in...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 53

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 51

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 44

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 130

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 67

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 22

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Holland America Tests Asia Demand With Eurodam Debut

Updated Category News Views 128

Cherry blossoms are not normally the sort of thing that gets my investor blood moving, but a ship deployment decision does. Holland America Line is sending Eurodam into Asia for its first season there from September 2028 through May 2029, and it is plainly trying to sell more than transportation between postcard ports. The pitch is time: five new ports, 14 ports with...

Continue Reading

Top 5 Most Recently Viewed Articles

InsCorp, Inc. Experiences Significant Growth Impact in 2025

Updated Category News Views 229

InsCorp, Inc. Sees Improved Financial Metrics in 2025 InsCorp, Inc. (OTCQX: IBTN) has announced results for the second quarter of 2025, demonstrating a noticeable upward trend in earnings per share (EPS) at $0.73, an increase from $0.57 in the prior quarter and $0.63 over the same period last year. Jim Rieniets, the President and CEO of INSBANK, expressed optimism about...

Continue Reading
Revance Celebrates National Sunscreen Day with Times Square Billboard

Updated Category News Views 223

Revance Celebrates National Sunscreen Day with a Bold Message Revance is thrilled to commemorate National Sunscreen Day with a vibrant digital billboard in Times Square. This event not only marks a celebration of Blue Lizard® Australian Sunscreen but also highlights the importance of sun safety as the summer season approaches. Blue Lizard is recognized as the leading...

Continue Reading
Exploring Noah Holdings' Strategic Vision for Global Growth

Updated Category News Views 523

Noah's Global Expansion and Innovative Services Noah Holdings has actively pushed the envelope in providing innovative financial services tailored to meet the diverse wealth management requirements of its clients. This year marks a significant chapter in their journey toward international expansion, where they are introducing groundbreaking solutions along with targeted...

Continue Reading
Streamline Your Taxes: Harness QuickBooks Reports Now

Updated Category News Views 21

QuickBooks: Not Just for Bookkeeping Anymore Taxes can be a pain, but if you're rocking QuickBooks, there's a silver lining. Karen Eberhart Metcalfe, the accounting whiz from Bolingbrook, IL, assures us that this tool isn't merely for ticking boxes in bookkeeping; it's your ace for navigating tax season with less sweat and more precision. When you’ve got those reports...

Continue Reading
Vistra's Options Trading Insights: What Big Investors Indicate

Updated Category News Views 177

Understanding Vistra's Options Trading Landscape Investors are closely observing the options trading activity for Vistra (NYSE: VST) as it indicates a notable bearish sentiment among significant traders. Retail traders would benefit from being aware of these trends. Current Market Sentiment Recent data revealed on options trading history highlights that a recognizable...

Continue Reading